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Abstract
Background: Donor-specific blood transfusion (DST) prior to solid organ transplantation has been shown to induce long-
term allograft survival in the absence of immunosuppressive therapy. Although the mechanisms underlying DST-induced
allograft tolerance are not well defined, there is evidence to suggest DST induces one or more populations of antigen-
specific regulatory cells that suppress allograft rejection. However, neither the identity nor the regulatory properties of
these tolerogenic lymphocytes have been reported. Therefore, the objective of this study was to define the kinetics,
phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft
transplantation (LTx).
Methodology/Principal Findings: Tolerance to Dark Agouti (DA; RT1
a) rat liver allografts was induced by injection (iv) of
1 ml of heparinized DA blood to naı ¨ve Lewis (LEW; RT1
l) rats once per week for 4 weeks prior to LTx. We found that
preoperative DST alone generates CD4
+ T-cells that when transferred into naı ¨ve LEW recipients are capable of suppressing
DA liver allograft rejection and promoting long-term survival of the graft and recipient. However, these DST-generated T-
cells did not express the regulatory T-cell (Treg) transcription factor Foxp3 nor did they suppress alloantigen (DA)-induced
activation of LEW T-cells in vitro suggesting that these lymphocytes are not fully functional regulatory Tregs. We did observe
that DST+LTx (but not DST alone) induced the time-dependent formation of CD4
+Foxp3
+ Tregs that potently suppressed
alloantigen-induced activation of naı ¨ve LEW T-cells in vitro and liver allograft rejection in vivo. Finally, we present data
demonstrating that virtually all of the Foxp3-expressing Tregs reside within the CD4
+CD45RC
2 population whereas in which
approximately 50% of these Tregs express CD25.
Conclusions/Significance: We conclude that preoperative DST, in the absence of liver allograft transplantation, induces the
formation of CD4
+ T-cells that are not themselves Tregs but give rise directly or indirectly to fully functional
CD4
+CD45RC
2Foxp3
+Tregs when transferred into MHC mismatched recipients prior to LTx. These Tregs possess potent
suppressive activity and are capable of suppressing acute liver allograft rejection. Understanding the mechanisms by which
preoperative DST induces the generation of tolerogenic Tregs in the presence of alloantigens may lead to the development
of novel antigen-specific immunological therapies for the treatment of solid organ rejection.
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Introduction
Transplantation of different organs across major histocompat-
ability complex (MHC) barriers induces potent effector responses
by the immune system resulting in the substantial tissue injury and
rejection of the allograft. Indeed, transplantation of certain organ
allografts results in rapid rejection of the allograft in the absence of
immunosuppressive therapy. With the advent and long-term use of
potent immunosuppressive agents, acute rejection has been
substantially reduced and allograft survival has increased dramat-
ically over the past two decades[1]. However, these nonspecific
immunosuppressive drugs possess several significant limitations
and side effects which may limit their long-term uses[2,3]. The
ideal therapy for inducing long-term tolerance to tisse allografts
would be induction of antigen-specific suppression of the acute and
chronic rejection without compromising host defenses. Over the
past 20 years there have been numerous experimental and clinical
reports demonstrating that tolerance can be induced to certain
allografts by infusion of different donor cell preparations[4,5].
Indeed, donor-specific blood transfusion (DST) has been shown to
induce immune hyporesponsiveness and tolerance to a number of
different tissues including heart, kidney and liver in the absence of
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example, that DST significantly prolongs heart or liver allograft
survival however mononuclear/lymphocyte cell infiltration into
DST-treated allografts was found to be as great (or greater) when
compared to untreated grafts in early phase following transplan-
tation[13,14].These data suggested that deletion of alloreactive
T-cells may not be the mechanism by which allografts are
protected from acute rejection. In addition, it has been shown that
donor MHC positive-cells accumulate in the spleen and lymph
nodes at 12 hr following DST and that splenectomy performed at
the time of transplantation abrogated tolerance to liver allo-
grafts[15], suggesting the importance of secondary lymphoid
system for tolerance induction. In addition, expression of the
immunoregulatory cytokines TGFb and IL-4[13] as well as the
numbers of CD4
+CD45RC
2 T-cells[14] have been reported to be
increased in the tolerated allografts suggesting the presence
regulatory T-cells (Tregs). Indeed, adoptive transfer of
CD4
+CD45RC
2 T-cells obtained from rats that received DST
and heart allograft into naı ¨ve recipients induced long term
tolerance to heart allografts suggesting the presence of Tregs within
this lymphocyte population[16]. However, neither the identity nor
the regulatory properties of the Tregs present within the
CD4
+CD45RC
2 T-cell subset responsible for DST-induced
allograft tolerance was investigated. Therefore, the objective of
this study was to characterize the kinetics, phenotype and
suppressive function of the Tregs induced by DST alone or in
combination with liver allograft transplantation (LTx). We report
that preoperative DST induces the formation of CD4
+ T-cells
that are not themselves classical Tregs but develop into fully
functional Foxp3
+ Tregs or help to induce the formation of
CD4
+CD45RC
2Foxp3
+ Tregs following allograft transplantation.
Materials and Methods
Animals
Inbred male MHC-mismatched Dark Agouti (DA; RT1
a) rats,
Lewis (LEW; RT1
l) rats and Piebald virol Glaxo pigmented rats
(PVG; RT1
c) were purchased from Harlan Laboratories (India-
napolis, IN) and used as donors, recipients and third party donor
controls, respectively. All animals were fed normal rat food ad
libitum with free access to water. The care and use of laboratory
animals conformed to the National Institutes of Health and
LSUHSC guidelines.
Orthotopic Liver Transplantation and Donor Specific
Blood Transfusion (DST)
DA liver allografts were orthotopically transplanted into LEW
recipients according to the method described by Kamada et al
[17]. The cold ischemia time was ,60 min and unhepatic time
was ,14 min. Transplanted animals were monitored on a daily
basis. For the induction of tolerance, 1 ml of heparinized DA
blood was administered (i.v.) to naı ¨ve LEW rats (125 g,149 g)
once a week for 4 weeks prior to LTx as previously described[18].
Antibodies and Reagents and Analysis
Pacific Blue conjugated mouse anti rat CD4 antibody (W3/25) was
obtained from AbD Serotec (Raleigh, NC). PerCP conjugated mouse
anti-rat CD8a (OX-8), FITC conjugated mouse anti-rat CD25 (OX-
39), FITC conjugated mouse anti-rat CD45RC (OX-22), PE
conjugated mouse anti-rat CD45RC (OX-22) and APC conjugated
mouse anti-rat CD3 (1F4) antibodies were purchased from BD
Bioscience (San Jose, CA). PE anti-mouse/rat Foxp3 (FJK-16s) was
from eBioscience (San Diego, CA). Splenocytes (1610
6 cells) or
lymph nodes (LNs) surrounding the portal and splenic veins were
stained with indicated antibodies and analyzed using flow cytometer
(FACSVantage SE, BD Bioscience, San Jose, CA). For intracellular
staining of Foxp3, cells stained with surface marker antibodies were
fixed, permeabilized and incubated with PE conjugated anti-mouse/
rat Foxp3 according to the manufacturer’s protocol. Corresponding
isotype-matched control mAbs were used in all flow cytometric
staining procedures. All flowcytometric analysis was done using
FlowJo software (Tree Star Inc. San Diego CA, ver7.2.5).
T-Cell Isolation
Spleens were obtained fromnaı ¨veLEWratsorLEWratssubjected
to 1 to 4 weekly injections of DST alone (DSTx1 to DSTx4) or 4
weekly injections of DST in combination with LTx (DSTx4+LTx).
Single cell suspensions were prepared and MHC class II
+ cells were
depleted using MACS Rat MHC-II MicroBeads (Miltenyi Biotec,
Auburn, CA) according to the manufacturer’s protocol to yield a
lymphocyte population highly enriched (.95%) for CD3
+ T-cells.
Positive or negative selection for CD4
+ and/or CD8
+ cells were
performed using MACS Rat CD4 and/or CD8 Microbeads. Cells
stained for CD4 and CD45RC or CD25 mAb were sorted using the
FACSAria Cell-Sorting System (BD Bioscience, San Jose, CA). Each
population was determined to be .98% pure by flow cytometry.
Mixed Lymphocyte Reaction (MLR)
Unfractionated T-cells, CD4
+ T-cells or CD8
+ T-cells
(1610
5cells) from LEW rats were cultured in triplicate in U-
bottom 96 well plates with 2610
5 irradiated (2,000 rad) DA
splenocytes for 5 days at 37uC in complete RPMI-1640 as
described previously[19]. For suppression assays, 1610
5 CD4
+ T-
cells or CD8
+ T-cells from naı ¨ve or treated LEW rats were added
to the standard MLR assay (using naı ¨ve LEW T-cells as responder
cells) as described above. One mCi of [
3H]-thymidine was added to
each well for the last 18 hr incubation and [
3H]-thymidine
incorporations were quantified.
Quantitative mRNA Cytokine Determinations
Real time PCR (RT-PCR) was used to quantify the expression
of IL-10, TGFb and IFNc using the Applied Biosystems 7300
Real-Time PCR System and Power SYBR green Master Mix
(Foster City, CA). HPRT served as internal control. All expression
levels of the target genes were normalized to the housekeeping
gene HRPT.
Adoptive Transfer Studies
Naı ¨ve LEW rats were lightly-irradiated (100 rad) and varying
numbers of whole splenocytes or indicated T-cell populations
obtained from naı ¨ve, DSTx4 alone or DSTx4+LTx rats were
injected (iv.) immediately following irradiation. Twenty four hours
following adoptive transfer, DA livers were transplanted into the
LEW recipients.
Statistics
Mann-Whitney U tests were performed for comparison of
means. Kaplan-Meier survival graphs were made and Log rank
comparison of the groups was used to calculate p values. Statistical
level of significance was defined as p,0.05.
Results
Allograft Tolerance Is Maintained for 30 but Not 100 Days
Following DST Treatment
We have previously reported that DST induces tolerance to DA
liver allografts and long term survival of LEW recipients[18]. In
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increased survival from 0% for rats that did not receive DST to
25%, 50% and 88% for recipients that received DST once per
week for 1, 2, or 4 weeks prior to LTx respectively[18]. In the
current study, we extend these original findings by demonstrating
that tolerance induced by 4 weekly treatments of DA donor blood
(DSTx4) is maintained even when LTx was delayed for more than
one month (37 days) following the last DST treatment (Fig. 1).
However, the tolerogenic effects of DSTx4 were lost when LTx
was delayed .100 days following the last DST treatment (Fig. 1).
It should be noted that tolerance to liver allografts in this strain
combination is donor/antigen-specific as rat blood transfusion
with a different genetically different strain of rat (e.g. Brown
Norway rat) does not prevent DA allograft rejection and
conversely, DA blood transfusion doe not induce tolerance to
liver allografts obtained from a genetically different rat (e.g. PVG)
2when transplanted into LEW rats[18].
DST Alone or in Combination with LTx Affects
Alloantigen-Induced CD4
+ T-Cell Activation In Vitro
As a first attempt to determine whether DST alone or in
combination with LTx affects alloreactive responses of T-cells, we
performed a series of MLR experiments in vitro. We found that
alloantigen (DA)-induced activation of T-cells obtained from LEW
rats pretreated at different times with DST alone was very similar
to that of naı ¨ve T-cells (Fig. 2A). Alloantigen-induced activation of
T-cells obtained from LEW animals subjected to DSTx4+LTx was
significantly decreased in a time-dependent manner (Fig. 2A). This
suppression of alloantigen-induced proliferation appeared to be
dependent upon the combination of both DST and LTx as T-cells
obtained from rats at various days following DSTx4 alone
maintained their ability to respond to irradiated DA splenocytes
(Fig. 2A). We found that the CD4
+/CD8
+ ratio (70/30) in these
responder T-cells did not change throughout this experiment (data
not shown).
To ascertain which T-cell subset was responsible for the
suppressive effect observed in Figure 2A, we performed the same
types of experiments as described above with CD4
+ or CD8
+
T-cells obtained from the different groups of rats. Interestingly, we
found that alloantigen-induced proliferation of CD4
+ T-cells
obtained from rats that were subjected to multiple weekly DST
increased in a dose-dependent fashion to more than 2–3 fold when
compared to naı ¨ve CD4
+ T-cells (Fig. 2B). CD4
+ T-cells obtained
from rats subjected to DSTx4+LTx were much less responsive to
alloantigen-induced proliferation such that the proliferative
activity of CD4
+ T-cells obtained from LEW animals at 30 and
Figure 1. Donor specific blood transfusion (DST) induces
tolerance to liver allografts. LEW rats were pretreated with
1 ml of heparinized DA blood (DST) once per week for 4 weeks
prior to DA liver transplantation (LTx). LTx was performed 7 days
following last DST treatment (DSTx4+LTx 7days; black squares, n=10).
DSTx4+LTx 37days (white squares, n=5) and DSTx4+LTx 107days (white
diamonds, n=4) represent LEW rats pretreated once per week for 4
weeks with DST with LTx performed at 37 or 107 days following last DST
treatment. Some animals did not receive DST but did receive LTx (black
triangles, n=7). *P,0.05 compared with LTx alone.
doi:10.1371/journal.pone.0007840.g001
Figure 2. Alloreactive responses of T-cells obtained from LEW
rats subjected to DST alone or DSTx4+LTx in vitro. (A) T-cells
(1610
5) from LEW rats subjected to one or more weekly DST treatments
with or without LTx were incubated with irradiated DA splenocytes
(2610
5) for 5 days to induce T-cell proliferation. The dotted line shows
the proliferation of T-cells from naı ¨ve LEW rats. DSTx4 alone at 14, 37
and 107 days represent alloreactive responses of T-cells obtained from
LEW rats pretreated with 4 weekly DST treatments and then harvested
at 14, 37 and 107 days following the last DST treatment (no LTx).
*P,0.05 compared with proliferation of T-cells from Naı ¨ve LEW rat. (B)
CD4
+ T-cells (1610
5) from LEW rats subjected to one or more weekly
DST treatments with or without LTx were incubated with irradiated DA
splenocytes as described above. The dotted line shows the proliferation
of CD4
+ T-cells from naı ¨ve LEW rats. *P,0.05 compared with Naı ¨ve LEW
rat.
#P,0.05 compared with DSTx4.
"P,0.05 compared with DSTx4
alone at 14 d. Data represent mean6SD from at least three
independent experiments.
doi:10.1371/journal.pone.0007840.g002
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decreased as compared to naı ¨ve CD4
+ T-cells (Fig. 2B). As with
unfractionated T-cells, this decreased proliferative activity of
CD4
+ T-cells appeared to be dependent upon the presence of both
DST and LTx as CD4
+ T-cells obtained from rats at 14 and 37
days following DSTx4 alone maintained their hyper-proliferative
state in response to alloantigens. However, CD4
+ T-cells obtained
from rats at 107 days following DSTx4 alone exhibited only 50%
the proliferative response of cells obtained from rats at 14 days
post DST treatment (Fig. 2B). Finally, we found that CD8
+ T-cells
obtained from naı ¨ve LEW rats or LEW animals treated with DST
alone or in combination with LTx responded to irradiated DA
splenocytes with ,10% the proliferative response of CD4
+ T-cells
(data not shown).
DST Alone or in Combination with LTx Affects the
Regulatory Properties of CD4
+ or CD8
+ T-Cells In Vitro
We next investigated the ability of CD4
+ or CD8
+ T-cells
obtained from the different groups of rats to suppress alloantigen-
induced activation of naı ¨ve LEW T-cells in vitro. We found that
CD4
+ T cells obtained from rats treated with one or multiple DST
were not able to inhibit alloantigen-induced T-cell proliferation
(Fig. 3A). However, when DSTx4 was combined with LTx, CD4
+
T-cells obtained from these animals at 7, 30 and 100 days post
LTx acquired potent suppressive activity (Fig. 3A). Again this
effect appeared to be dependent upon the presence of donor
antigens (ie allograft), as CD4
+ T-cells from LEW rats treated with
DSTx4 alone at 14 or 107 days post DST were unable to suppress
alloantigen-induced proliferation of naı ¨ve LEW T-cells (Fig. 3A).
In contrast to CD4
+ T-cells, CD8
+ T-cells obtained from rats
treated with DST alone displayed significant suppressive activity
under the same experimental conditions (Fig. 3B). This suppressive
activity was abrogated at 30 or 100 days after LTx. CD8
+ T-cells
maintained their suppressive activity for .100 days following DST
treatment alone (Fig. 3B). This suppressive activity was donor
antigen specific because CD8
+ T-cells did not suppress naı ¨ve
T-cell proliferation induced by irradiated PVG splenocytes (third
party) and CD8
+ T cells from rats receiving PVG blood
transfusion were not able to inhibit naive T cell proliferation
induced by irradiated DA splenocytes (data not shown).
Time-Dependent Increase in CD4
+T-Cells Expressing
Foxp3 and CD25 in DSTx4+LTx Recipients
To determine whether DST alone or in combination with LTx
induces the generation of Foxp3-expression regulatory T-cells
(Tregs), we evaluated whether DST treatment in absence or
presence of LTx affects the percentages of different T-cell subsets
thought to possess regulatory function in vivo. We found that DST
treatment alone did not alter expression of Foxp3, CD25 or
CD45RC on CD4
+ T-cells obtained from spleens of these rats
(Fig. 4A and 4B). In addition, no alterations in expression of these
markers were observed when spleens were obtained from rats at
7days following LTx (Fig. 4B). We did observe significant increases
in Foxp3 and CD25 but not CD45RC expression on CD4+ T-cells
obtained from rats at 30, 60 and 100 days following DSTx4+LTx
compared to those from naı ¨ve rats (Fig. 4B). Interestingly, both
CD25 and Foxp3 expression were increased in the CD45RC
2
population from long term survivors (DSTx4+LTx .100day
survival) despite the fact that percentages of CD4
+CD45RC
2
T-cells remained unchanged when compared to naı ¨ve T-cells or
T-cells obtained from DSTx4 treated rats (Fig. 4A and 4B). In
addition, both Foxp3
+CD25
2 and Foxp3
+CD25
+ cells significantly
increased in a time-dependent manner in the CD4
+ T-cell
population obtained at 30 days following LTx (Fig. 4C). Although
CD4
+CD25
+ T-cells also increased, Foxp3
2 T-cells increased more
than did Foxp3
+ T-cells in CD4
+CD25
+ population. In fact, we
found that only 50% of CD4
+CD25
+ T cells expressed Foxp3
+ in
the long term survivors (Fig. 4C). No alterations in expression of
CD25, CD45RC and/or Foxp3 were noted in CD8
+ T-cells and
similar data were obtained for T-cells obtained from LNs
surrounding the portal vein (data not shown).
Figure 3. Suppressive activity of CD4
+ or CD8
+ T-cells from LEW
rats subjected to DST alone or DSTx4+LTx in vitro. (A) CD4
+
T-cells (1610
5) from rats subjected to one or more weekly DST
treatments with or without LTx were incubated with donor (DA)
irradiated splenocytes (2610
5) in the presence of naı ¨ve LEW T-cells
(1610
5) as described above. The dotted line shows the proliferation of
T-cells from naı ¨ve LEW rats (designated as 100%). DSTx4 alone at 14 and
107 days represent suppressive activity of CD4
+ T-cells obtained from
LEW rats pretreated with 4 weekly DST treatments and then harvested
at 14 and 107 days following the last DST treatment. (B) CD8
+ T-cells
obtained from rats subjected to one or more weekly DST treatments
with or without LTx were incubated with donor (DA) irradiated
splenocytes (2610
5) in the presence of naı ¨ve LEW T-cells (1610
5)a s
described above. The dotted line shows the proliferation of T-cells from
naı ¨ve LEW rats (designated as 100%). DSTx4 alone at 14 and 107 days
represent suppressive activity of CD8
+ T-cells obtained from LEW rats
pretreated with 4 weekly DST treatments and then harvested at 14 and
107 days following the last DST treatment. Combined results are shown
as mean6SE. * and
# P,0.05 compared with either CD4
+ T-cells or
CD8
+ T-cells from naı ¨ve LEW rat.
doi:10.1371/journal.pone.0007840.g003
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+CD25
+ T-Cells from Long Term Survivors Express
More TGFb mRNA than Do Foxp3
2CD25
+ T-Cells
Message levels of the different cytokines from CD4
+Foxp3
+CD25
+
T-cells obtained from spleens of long term survivors (DSTx4+LTx
rats; survival.100 days) were quantified and compared to those
expressed by CD4
+Foxp3
2CD25
+ T-cells from these same animals.
We found that although TGFb, IL-10 and IFN-c mRNA expression
was increased in Foxp3
+ vs. Fop3
2 T-cells, only TGFb expression
was significantly increased (Fig. 5).
Adoptive Transfer of CD4
+ T-Cells Obtained from Rats
Subjected to DST Alone Prolongs Survival of Rat Liver
Allografts
We next wished to determine whether adoptive transfer of
whole splenocytes obtained from the various groups of rats into a
second set of naı ¨ve lightly irradiated (100 rad) LEW recipients
24 hrs prior to LTx induced long term survival as described
previously for heart, kidney or skin allografts[12,16,19,20].
Adoptive transfer of splenocytes from naı ¨ve LEW donors resulted
in a 100 day survival of only 15% of recipients that received LTx
(Fig. 6A). Transfer of splenocytes from LEW rats treated with
DSTx4 alone increased survival to 40% however this increase was
not statistically significant. One hundred day survival was
increased to 90–100% when splenocytes from long term survivors
were transferred into lightly irradiated LEW recipients prior to
LTx. Furthermore, we observed a time-dependent increase in
survival depending upon when the splenocytes were isolated from
DSTx4+LTx rats. We found that adoptive transfer of splenocytes
obtained from DSTx4+LTx rats at 7, 14, 30 and 60 days following
LTx increased survival from 15% in rats that received naı ¨ve
splenocytes to 50, 80, 100 and 100%, respectively at 100 days post
LTx (Fig. 6A).
Although whole splenocytes from DST-alone rats did not
increase significantly survival of a second set of recipients, our in
vitro data suggested that DST alone induces the production of
CD8
+ T-cells that suppresses alloantigen-induced proliferation of
naı ¨ve T-cells (Fig. 3B) and promotes a hyper-proliferative response
of CD4
+ T-cells to alloantigens (Fig. 2B). Therefore, we next
investigated whether adoptive transfer of T-cells enriched for
either CD8
+ or CD4
+ cells obtained from rats subjected to DSTx4
alone into naı ¨ve LEW animals prior to receiving LTx affected
allograft survival in vivo. Unexpectedly, we found that adoptive
transfer of CD8
+ T-cells obtained from DSTx4 treated rats to
lightly irradiated (100 rad) LEW recipients did not prolong
allograft survival whereas adoptive transfer of CD4
+ T-cells from
DSTx4-treated rats significantly increased allograft survival
compared to the rats that received naı ¨ve CD4
+ or CD8
+ T-cells
(Fig. 6B). Moreover, we observed similar increases in Foxp3 and
CD25 expression on CD4
+T-cells obtained from the second set of
recipients that received CD4
+ T-cells from rats subjected DSTx4
alone when analyzed by flow cytometry(100days after LTx; data
not shown).
Alloantigen Specific Tregs Induced by DST+LTx Are
CD4
+CD45RC
2Foxp3
+ T-Cells
For the next series of experiments, we enriched splenocytes
obtained from long term survivors (DSTx4+LTx; .100day
survival) for CD4
+ T-cells and transferred these cells into lightly
irradiated LEW recipients 24 hr prior to LTx. We found that the
100 day survival increased significantly from 21% in irradiated
LEW rats that received LTx but no T-cells to almost 90% for rats
that received CD4
+ T-cells from long term survivors (Fig. 6C).
Because most, if not all of the Foxp3 expressing CD4
+ T-cells are
Figure 4. Alterations in different CD4
+ populations in spleens
obtained from LEW rats subjected to DST in the absence or
presence of LTx. (A) Representative flow cytometric analysis of
splenocytes harvested from either naı ¨ve, DSTx4 alone or DSTx4+LTx rats
100days after LTx. Cells are gated on CD3
+ CD4
+ T-cells. Isotype-
matched control antibodies were used to set all gates. (B) Percentages
of Foxp3
+, CD25
+ or CD45RC
2 T-cells within the CD4
+ T-cell population
in spleens from naive, DST treated or DSTx4+LTx rats. (C) Percentages of
Foxp3
+CD25
2, Foxp3
+CD25
+ or Foxp3
2CD25
+ T-cells within the CD4
+ T-
cell population in spleens from naı ¨ve, DST treated or DSTx4+LTx rats.
The results are expressed as mean6SE from at least three individual
experiments for each group. *
# " P,0.05 compared with correspond-
ing population in naı ¨ve group.
doi:10.1371/journal.pone.0007840.g004
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+CD45RC
2 T-cell population of long term
survivors, we sorted the DSTx4+LTx splenocytes into the
CD4
+CD45RC
+and CD4
+CD45RC
2 populations and trans-
ferred these cells to a second set of naı ¨ve recipients. Adoptive
transfer of CD4
+CD45RC
2 T-cells dramatically increased the 100
day survival of the recipients to 100% whereas transfer of
CD4
+CD45RC
+ T-cells did not increase survival when compared
to control LTx rats that did not receive T-cells (Fig. 6C). In
addition, adoptive transfer of CD4
+CD25
+ or CD4
+CD25
2 cells
from DSTx4+LTx donor rats increased survival in both groups,
suggesting the presence of Tregs in both the CD25
+ and CD25
2
T-cell populations (Fig. 6C).
Discussion
Data presented in the current study demonstrate the novel
finding that adoptive transfer of DST-primed CD4
+ T-cells
suppresses liver allograft rejection despite the fact that these T-
cells express little or no Foxp3 and possess no MLR suppressive
activity in vitro. These are somewhat surprising findings given the
fact that previous studies have demonstrated that transfer of whole
splenocytes from animals treated with DST alone is insufficient to
induce long term survival of heart and kidney allografts[16,20,21].
Indeed, we did observe that adoptive transfer of whole splenocytes
obtained from DST treated rats failed to significantly extend
allograft survival when compared to rats that were injected with
splenocytes from naı ¨ve LEW donors (Fig. 6A). However, when
CD4
+ (but not CD8
+ T-cells) were obtained from rats that had been
pretreated with DSTx4 alone were transferred into naı ¨ve
recipients 24 hrs prior to LTx, we observed a significant increase
in survival of the liver allografts compared to LTx animals
receiving naı ¨ve CD4
+ T-cells (Fig. 6B). Our data coupled to data
from other laboratories [22,23] suggest that CD8
+ T-cells may be
required for the DST-induced priming of CD4
+ T-cells but are not
themselves the cellular mediators of DST-induced tolerance to
tissue allografts. Currently, it is not clear why DST-primed whole
splenocytes fail to induce tolerance whereas CD4
+ T-cells enriched
from DST-primed splenocytes do. It may be that one or more
lymphocyte populations (ie CD8
+ T-cells, B-cells) generated in
DST-primed animals ‘‘interfere’’ with or suppress the develop-
ment and/or regulatory function of DST-primed CD4
+ T-cells.
Indeed, when CD8
+ T-cells are removed from unfractionated
DST-primed T-cells, the remaining CD4
+ T-cells respond to
alloantigens with a 2–3 fold higher proliferative response (Fig. 2B)
suggesting that CD8
+ T-cells actively suppress alloantigen
activation of CD4
+ T-cells. This idea is supported by our data
demonstrating that addition of DST-primed CD8
+ T-cells
potently suppressed alloantigen-induced activation of naı ¨ve T-
cells in vitro (Fig. 3B). Obviously, the relationship between CD4
+
and CD8
+ T-cells during DST priming and maintenance periods
is in need of further investigation. Another lymphocyte population
that may play a role in regulating the development and/or
function of DST-primed CD4
+ Tregs in vivo is the B-cell. It is
known for example that B-cells block Treg function thereby
exacerbating Th1-mediated gut inflammation in a mouse model of
Crohn’s disease[24].
The mechanisms by which transfer of DST-primed CD4
+ T-
cells suppress allograft rejection in vivo have not been identified
however these T-cells appear to represent a Treg precursor
population that develops into fully functional Tregs in the presence
of donor antigens. Closer examination of the phenotype and
functional properties of these DST-primed CD4
+ T-cells vs. those
obtained from DSTx4+LTx clearly reveal 2 distinct populations of
T-cells. For example, DST-primed CD4
+ T-cells respond to
Figure 5. Cytokine mRNA Expression by Foxp3
+CD25
+ and Foxp3
2CD25
+T-cells from long term survivors. Message levels of TGFb, IL-10
and IFNc in CD4
+Foxp3
+CD25
+ T-cells obtained from spleens of long term survivors (DSTx4+LTx rats; survival.100 days) were quantified and
compared to those expressed by CD4
+Foxp3
2CD25
+ T-cells obtained from these same animals. Quantitative Real-time (RT)-PCR was used to quantify
cytokine mRNA expression in each population. HRPT was used as an endogenous control to normalize each sample. Data represent mean6SD.
*P ,0.05 compared with Foxp3
2CD25
+ T-cells. N=5 for each group.
doi:10.1371/journal.pone.0007840.g005
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treatment groups. (A) Adoptive transfer of whole splenocytes from DSTx4+LTx rats induces tolerance to liver allografts in naı ¨ve LEW recipients in a
time-dependent manner. Splenocytes (250610
6 cells) obtained from naı ¨ve (black diamonds, n=7), DSTx4 (white diamonds,n=9), DSTx4+LTx at 7 d
post LTx (white circles, n=4), DSTx4+LTx at 14 d post LTx (black circles, n=5), DSTx4+LTx at 30 d post LTx (white squares, n=4), DSTx4+LTx at 60 d
post LTx (hash squares, n=4) or DSTx4+LTx at 100 d post LTx (black squares, n=9) were injected into lightly-irradiated (100rad) LEW rats one day
before LTx. Control rats received 100 rad irradiation and received LTx but no cell transfer (black triangles, n=14). *P,0.05 compared with no cell
transfer. (B) Adoptive transfer of CD4
+ but not CD8
+ T-cells obtained from DST-primed LEW rats induces tolerance to liver allografts in naive LEW
recipients. CD4
+ (white squares, n=6) or CD8
+ (white diamonds, n=6) T-cells (50610
6 cells) obtained from spleens of naı ¨ve rats and CD4
+ (black
squares, n=6) or CD8
+ (black diamonds, n=6) T-cells (50610
6 cells) obtained from spleens of DSTx4 rats were injected into lightly-irradiated (100 rad)
LEW rats one day before LTx.
#P=0.05 compared with naı ¨ve CD4
+ (white squares). (C) Adoptive transfer of CD4
+CD45RC
2, CD4
+CD25
+ or
CD4
+CD25
2 T-cells induces tolerance to liver allografts in naı ¨ve LEW recipients. CD4
+ T-cells (50610
6 cells; (black squares, n=7); CD4
+CD45RC
2
T-cells(20610
6 cells; black diamonds, n=5); CD4
+CD45RC
+ T-cells (20610
6 cells; white diamonds,n=5); CD4
+CD25
2 T-cells (40610
6 cells; black circles,
n=5); and CD4
+CD25
+ T-cells (10610
6 cells, white circles, n=5) from DSTx4+LTx at 100days post LTx were transferred into lightly irradiated LEW rats
one day prior to LTx. *P,0.05 compared with no cell transfer (black triangles).
doi:10.1371/journal.pone.0007840.g006
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+
T-cells obtained from DSTx4+LTx exhibit little or no alloantigen-
induced proliferation in vitro (Fig. 2B). It may be that the rapid
infiltration and proliferation of T-cells within the transplanted
allografts following DST treatment as observed by oth-
ers[21,25,26] represents alloantigen-induced activation of DST-
primed CD4
+ T-cells. A second set of observations that suggest
DST-primed CD4
+ T-cells are distinct from functional Tregs
induced by DSTx4+LTx is that DST-primed T-cells express little
or no Foxp3 and do not suppress alloantigen-induced activation of
naı ¨ve T-cells in vitro whereas DSTx4+LTx CD4
+ Tregs are
CD4
+CD45RC
2Foxp3
+ and dramatically suppress alloantigen-
induced proliferation of naı ¨ve T-cells in vitro (Fig. 3A and 4).
Previous work from our laboratory have suggest the generation of
fully functional Tregs is both dose and time dependent with
respect to DST administration[18]. Data obtained in the current
study extend these observations by demonstrating that the
tolerance induced by DSTx4 is maintained even when LTx was
delayed by 30 days following the last DST treatment. Furthrmore,
we found that tolerace lost when LTx was delayed 100days post-
DST suggesting that alloantigen-primed CD4
+ T-cells have
extended but finite lifetimes in the absence of continuous
alloantigen exposure (Fig. 1). Although, the mechanisms by which
continuous alloantigen exposure is required for DST-induced,
long term tolerance have not been delineated, they may be related
to the strength of proliferative response of CD4
+ T-cells to donor
antigen (Fig. 2B). Taken together, we propose that DST-primed,
hyperproliferative CD4
+ T-cells represent a precursor population
that may ultimately develop into fully functional Tregs
(CD4
+CD45RC
2Foxp3
+) in the presence of alloantigens ex-
pressed by the liver graft (Fig. 2, 4 and 6A). Indeed, it may be that
the sinusoidal endothelial cells play an important role in inducing
tolerance to alloantigens.
Another novel finding we have made in the current study is the
time-dependent increase in the suppressive activity of T-cells in
vitro (Fig. 2) and in vivo (Fig. 6A). We dmeonstrate that T-cells (or
splenocytes) isolated from DSTx4+LTx rats at 30, 60 and 100 days
post LTx are much more suppressive against alloantigen-induced
activation of T-cells as well as allograft rejection than were T-cells
isolated at 7 or 14 days post LTx (Fig. 2 and 6A). This time-
dependent increase in suppressive activity correlated well with
increased frequency of Foxp3-expressing Tregs (Fig. 4B and 4C).
These data contrast to those of Kitade and coworkers who
suggested that functional Tregs were present very early following
DST+heart allograft transplantation[16]. This conclusion was
based upon the observation that splenocytes, obtained at 5 days
following heart allograft transplantation (and preoperative DST),
could transfer tolerance to naı ¨ve recipients receiving heart
allografts[16]. However, it should be pointed out that .10 times
the number of splenocytes were required to suppress allograft
rejection in these specific studies when compared to the numbers
of splenocytes that were required for tolerance when obtained at
later times (14 or 30 days) following heart allograft transplanta-
tion[16]. Furthermore, adoptive transfer of splenocytes obtained at
5 days post transplantation induced less than 40% allograft
survival at 90 days following surgery[16]. Taken together, our data
suggest that the numbers of allo-antigen specific Tregs are small
and/or their suppressive function has not fully developed during
the first week or two following allograft transplantation. We
propose that DST-primed T-cells require several weeks to mature
into fully functional Tregs and that this process requires the
presence of alloantigens (e.g. allograft).
Finally, we present the novel observation that virtually all of the
Foxp3-expressing Tregs generated by DSTx4+LTx reside within
the CD4
+CD45RC
2 population and that these Tregs suppress
alloantigen-induced activation in vitro as well as induce long term
tolerance to liver allografts in vivo (Fig. 4A and 6C).
Although we did observe significant numbers of Foxp3-
expressing Tregs in the CD4
+CD25
+ population, we also identified
an equal number of CD
+Foxp3
+ Tregs present in the CD4
+CD25
2
subset. These data suggest that the CD45RC
2 population rather
than CD25
+ subset of CD4
+ T-cells contains the largest percentages
of functional Tregs in this animal model.
In summary, our data suggest that DST administration, in the
absence of allograft transplantation, induces the formation of
CD4
+ T-cells that are not Tregs themselves but give rise directly or
indirectly to fully functional CD4
+CD45RC
2Foxp3
+Tregs follow-
ing liver allograft transplantation.
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